CleanCap® Reagent GG is TriLink’s proprietary co-transcriptional capping reagent for in vitro transcription of 5’ capped mRNA resulting in a Cap 1 structure.
PLEASE NOTE: TriLink recommends using CleanCap AG (cat. no. N-7113 or N-7413) whenever possible. CleanCap AG
requires an AG initiator. CleanCap AG typically provides >90%
capped material generating a naturally occurring Cap 1 structure. Unlike
CleanCap AG, using CleanCap GG may result
in comparable ARCA transcriptional stuttering and yield.
Extinction Coefficient: 37,700
Lmol-1cm-1 at 260 nm
1161.6 g/mol (free acid)
≥95% by AX-HPLC
Shipped at 100 mM in H2
1 µmole: 10 µL
5 µmole: 50 µL
10 µmole: 100 µL
Certificate(s) of Analysis
1Final capping is dependent upon the CleanCap Reagent, DNA template and final mRNA sequence. Secondary structure due to RNA length and base composition can affect final capping efficiency.
containing the CleanCap technology are for internal research use only. Not for
use in diagnostic or therapeutic procedures. Use of CleanCap technology
may be covered by one or more patents or pending Patent Applications. www.trilinkbiotech.com/cleancap/license.asp.